Xalacom is contraindicated in patients with: Reactive airway disease including bronchial asthma or a history of bronchial asthma, severe chronic obstructive pulmonary disease; Sinus bradycardia, sick sinus syndrome, sino-atrial block, second or third degree atrioventricular block not controlled with pace-maker, overt cardiac failure, cardiogenic shock; Hypersensitivity to the active substances or to any of the excipients listed in Description.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
